Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial.
Journal of Thoracic and Cardiovascular Surgery.
Times cited: 17
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.
Journal of Clinical Oncology.
Times cited: 248